http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103651431-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-36 |
| filingDate | 2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103651431-B |
| titleOfInvention | Containing the ultra low volume liquids and its preparation method and application of pungent azoles mepanipyrim and methoxy acrylic bactericide composition |
| abstract | The invention discloses a kind of ultra low volume liquids containing pungent azoles mepanipyrim and methoxy acrylic bactericide composition and its preparation method and application, belong to technical field of pesticide, active component (I) mass percentage is 0.1% ~ 30%, active component (II) mass percentage is 1% ~ 40%, surfactant qualities percentage composition is 1% ~ 10%, solvent complements to 100%, described active component (II) is Fluoxastrobin, kresoxim-methyl, pyraclostrobin, mepanipyrim, oxime bacterium ester, one in ZEN 90160 and Enestroburin.Preparation method: first with partial solvent by after active component (I), (II) stirring and dissolving, then add surfactant and remaining solvent, be fully uniformly mixed, obtain final product.The present invention is directed to that the upper work efficiency existed of traditional farming control is low, labour intensity large, need that water is many, the defect of poor stability; And the problem such as the preventive effect of medicament itself is single, resistance is obvious and the lasting period is short and providing. |
| priorityDate | 2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.